Myasthenia gravis induced by pembrolizumab in a patient with metastatic Merkel cell carcinoma

被引：1
|
作者：
Pottier, C. [1 ]
El Habnouni, C. [1 ]
Kervarrec, T. [2 ,3 ]
Beltran, S. [4 ]
Samimi, M. [1 ,3 ]
机构：
[1] CHRU Tours, Dept Dermatol, Hosp Trousseau, Ave Republ, F-37044 Tours 9, France
[2] CHRU Tours, Dept Pathol, F-37044 Tours 9, France
[3] Univ Tours, INRA, ISP 1282, F-37000 Tours, France
[4] CHRU Tours, Dept Neurol, F-37044 Tours 9, France
来源：
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 2022年 / 149卷 / 02期
关键词：
Myasthenia gravis; Immune checkpoint inhibitors; Pembrolizumab; Immune adverse event;
D O I：
10.1016/j.annder.2022.01.002
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：142 / 145
页数：4
相关论文
共 50 条
  • [41] Pembrolizumab-induced myasthenia gravis: Two patients' experiences
    Montag, Leslie
    Piver, Rachael
    Vidalin, Amy
    Johnson, Marian
    Rungruang, Bunja
    Higgins, Robert
    GYNECOLOGIC ONCOLOGY REPORTS, 2024, 54
  • [42] FDA Accelerated Approval of Pembrolizumab for Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma
    Bradford, Diana
    Demko, Suzanne
    Jin, Susan
    Mishra-Kalyani, Pallavi
    Beckles, Aaliyah R.
    Goldberg, Kirsten B.
    Lemery, Steven
    Ward, Ashley
    Keegan, Patricia
    Pazdur, Richard
    ONCOLOGIST, 2020, 25 (07): : E1077 - E1082
  • [43] Pembrolizumab-associated mucous membrane pemphigoid in a patient with Merkel cell carcinoma
    Haug, V.
    Behle, V.
    Benoit, S.
    Kneitz, H.
    Schilling, B.
    Goebeler, M.
    Gesierich, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (04) : 993 - 994
  • [44] Therapy of the metastatic Merkel Cell Carcinoma with the Anti-PD-1 Antibody Pembrolizumab
    Meier, K.
    Wilhelmi, J.
    Lomberg, D.
    Spaenkuch, I
    Scheu, A.
    Leiter, U.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 171 - 171
  • [45] Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer
    Huh, So-Young
    Shin, Seong-Hoon
    Kim, Meyung Kug
    Lee, So-Young
    Son, Ki Hun
    Shin, Ha Young
    JOURNAL OF CLINICAL NEUROLOGY, 2018, 14 (01): : 115 - 117
  • [46] The Terrible Triad of Checkpoint Inhibition: A Case Report of Myasthenia Gravis, Myocarditis, and Myositis Induced by Cemiplimab in a Patient with Metastatic Cutaneous Squamous Cell Carcinoma
    Jeyakumar, Nikeshan
    Etchegaray, Mikel
    Henry, Jason
    Lelenwa, Laura
    Zhao, Bihong
    Segura, Ana
    Buja, L. Maximilian
    CASE REPORTS IN IMMUNOLOGY, 2020, 2020
  • [47] Successful rechallenge with avelumab in a patient with advanced Merkel cell carcinoma who presented pembrolizumab-induced myositis
    Bertold, Clemence
    Troin, Laura
    Chassang, Madleen
    Passeron, Thierry
    Doyen, Jerome
    Montaudie, Henri
    Picard-Gauci, Alexandra
    JEADV CLINICAL PRACTICE, 2023, 2 (04): : 940 - 943
  • [48] Myasthenia gravis exacerbation associated with pembrolizumab
    Zhu, Julia
    Li, Yuebing
    MUSCLE & NERVE, 2016, 54 (03) : 506 - 507
  • [49] Oculo-bulbar myasthenia gravis induced by cytokine treatment of a patient with metastasized renal cell carcinoma
    Rohde, D
    Sliwka, U
    Schweizer, K
    Jakse, G
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 50 (06) : 471 - 473
  • [50] Avelumab-induced Pneumonitis in Metastatic Merkel Cell Carcinoma
    Morimoto, Toshiki
    Yamasaki, Kei
    Isoshima, Yu
    Yatera, Kazuhiro
    INTERNAL MEDICINE, 2022, 61 (17) : 2697 - 2698
12345